secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2022-11-30T23:59:59+00:00
Accession:  0000926617-22-000062
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health appoints Marlene McLennan as interim CFO effective Dec 1, 2022
--------------------------------------------------------------------------------

- Marlene McLennan appointed interim CFO, effective December 1, 2022; prior CFO at Vestige Healthcare and other healthcare firms.
- Annual base salary of $350,400; eligible for bonus up to 50% of base subject to board approval.
- Stock option grants of 25,000 shares per 6-month term under 2019 Stock Incentive Plan.
- Severance lump sum of $60,000 if terminated without cause or non-renewal, subject to performance criteria.
- Employment agreement initial 6-month term, renewable up to 18 months total.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000092661722000062/0000926617-22-000062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000092661722000062/awh-20221128x8k.htm
  HTML page:      https://secwatch.observer/filing/0000926617-22-000062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer